Table 1 Socio- demographic and inclusion characteristics of the study population
Characteristics | Factors(Frequency) | % |
|---|---|---|
Age (years) Range | < 30 years (27) | 27.0 |
30–40 years (43) | 43.0 | |
> 40 years (30 ) | 30.0 | |
Sex | Female (53) | 53.0 |
Male (47) | 47.0 | |
BMI (kg/m2) | Low (47) | 47.0 |
Normal (31) | 31.0 | |
Overweight (7) | 7.0 | |
Obese (15) | 15.0 | |
Level of education | None (5) | 5.0 |
Primary (51) | 51.0 | |
Secondary (38) | 38.0 | |
Tertiary (6) | 6.0 | |
Monthly Income | < 50,000frs (77) | 77.0 |
> 50,000frs (23) | 23.0 | |
Alcohol intake | Yes (56) | 56.0 |
No (44) | 44.0 | |
Cigarette or Tobacco intake | No (73) | 73.0 |
Yes (27) | 27.0 | |
Year of diagnosis | < 1 Year (84) | 84.0 |
1–3 Years (4) | 4.0 | |
> 3 Years (12) | 12.0 | |
CD4 class (cells/ mm3) | < 200 (57) | 57.0 |
> 200 (43) | 43.0 | |
WHO stages | stage 1 (14) | 14.0 |
stage2 (45) | 45.0 | |
stage 3 (37) | 37.0 | |
stage 4 (4) | 4.0 | |
Drug type | TDF + 3TC + EFV(64) | 64.0 |
AZT + 3TC + EFV (22) | 22.0 | |
AZT + 3TC + NVP (14) | 14.0 |